Newer antibiotics for serious gram-positive infections
Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic
Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL
Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic
Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail firstname.lastname@example.org
Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.
Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.
ABSTRACTFour newer antibiotics are available to treat gram-positive bacterial infections that are resistant to traditional antibiotics and to vancomycin. They should preferably be used with the help of an infectious-disease consultant: specific therapy should be chosen on the basis of the bacteria involved, the site of infection, whether the patient has kidney or liver disease, other medications the patient is taking, and side effects that develop.